When a new D-dimer method is evaluated, it’s typically compared to an established D-dimer method using both an analytical and a clinical comparison. Analytical comparisons should be discouraged, as they do not give any useful information about the potential clinical usability of the assay. D-dimer assay comparisons...

Point-of-care testing (POCT) covers a broad range of pathology and non-pathology testing. The volume of POCT is rapidly increasing with an annual growth rate of 12-15 %. By virtue of its compactness, portability, and the feasibility of operation by non-laboratory personnel, where fast and accurate testing methods and...

Clinical sensitivity, clinical specificity and predictive values are frequently used as performance measure for a biochemistry assay. When D-dimer assay performance is presented, emphasis is often on the negative predictive value (NPV). However, predictive values are greatly influenced by the prevalence of the...

With the ultimate goal of improving patient care, adoption of point-of-care testing (POCT) continues to grow at a high rate. The ability to deliver fast and reliable results near the patient is a key driver for improving patient outcomes and optimizing clinical workflow. While there are many advantages, controlling...

Reprinted from Ann Lab Med 2014 Sep; 34(4):263-73. Procalcitonin (PCT) is used as a biomarker for the diagnosis of sepsis, severe sepsis and septic shock. At the same time, PCT has also been used to guide antibiotic therapy. This review outlines the main indications for PCT measurement and points out possible...

This article first appeared in Pathology in Practice (Hobba H, Silver L. Evolution of POC testing. Pathology in Practice 2013; 14 [2]: 63) and is reproduced here by kind permission (www.pathologyinpractice.com). © 2013 kdm communications limited Point-of-care (POC) testing has allowed the pathology department in...

D-dimer testing can combined with assessment of pretest probability be used to rule out VTE in patients with a sufficiently low pretest probability of VTE. Patients with a negative D-dimer result can be ruled out, while patients with a positive D-dimer result need to have imaging performed for confirmatory diagnosis. ...

This short review aims to put the diagnostic options provided by state-of-the-art POCT  technology into perspective with the clinical challenges faced by physicians treating patients presenting with acute dyspnea.  Natriuretic peptides, hemoglobin, D-dimers and venous blood gases play a key role in the early...

Barnsley Emergency Department (ED), which recruited patients into the RATPAC trial, initiated a point-of-care (POC) pathway for low-risk chest pain patients from December 2011. All patients who underwent POC testing for chest pain between December 2011 and July 2012 were identified. Patient notes were then examined...

Point-of-care pathology testing is becoming increasingly common in hospitals, clinics and doctors’ offices; anywhere where time is critical and results are required at the patient’s side.  However, results must be accurate and reproducible to be meaningful, and it is imperative that a close eye is kept on...